Press Releases

News Brief

Samsung Biologics to attend DCAT Week 2025


Samsung Biologics will be participating in DCAT Week 2025 in New York City on March 17-20 as part of efforts to further strengthen its global network.


The company will be sharing updates regarding Bio Campus II. Plant 5, the first facility of the new campus, will be operating next month and bring up the company’s total biomanufacturing capacity to 784,000 liters. Samsung Biologics also expanded into the ADC field this year, with a dedicated facility up and running.

The company’s leadership will be hosting a series of meetings with existing and potential clients at the InterContinental New York Barclay to discuss how our manufacturing and development capabilities can support clients’ programs.



Samsung Biologics will be participating in DCAT Week 2025 in New York City on March 17-20 as part of efforts to further strengthen its global network.


The company will be sharing updates regarding Bio Campus II. Plant 5, the first facility of the new campus, will be operating next month and bring up the company’s total biomanufacturing capacity to 784,000 liters. Samsung Biologics also expanded into the ADC field this year, with a dedicated facility up and running.

The company’s leadership will be hosting a series of meetings with existing and potential clients at the InterContinental New York Barclay to discuss how our manufacturing and development capabilities can support clients’ programs.

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION